Package 55513-079-01

Brand: imlygic

Generic: talimogene laherparepvec
NDC Package

Package Facts

Identity

Package NDC 55513-079-01
Digits Only 5551307901
Product NDC 55513-079
Product ID 55513-079_4d1843a8-7a83-4062-ba8c-4f97e2f1427b
Description

1 VIAL in 1 CARTON (55513-079-01) / 1 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2015-11-02
Brand imlygic
Generic talimogene laherparepvec
Sample Package No

Linked Drug Pages (1)

Imlygic ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRALESIONAL"], "spl_id": "4d1843a8-7a83-4062-ba8c-4f97e2f1427b", "openfda": {"upc": ["0355513079013", "0355513078016"], "unii": ["07730V90L6"], "rxcui": ["1721278", "1721283", "1721287", "1721289"], "spl_set_id": ["64ffb680-ea8c-42fc-9649-9e8c0eb77ddb"], "manufacturer_name": ["Amgen Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55513-079-01)  / 1 mL in 1 VIAL", "package_ndc": "55513-079-01", "marketing_start_date": "20151102"}], "brand_name": "Imlygic", "product_id": "55513-079_4d1843a8-7a83-4062-ba8c-4f97e2f1427b", "dosage_form": "INJECTION, SUSPENSION", "product_ndc": "55513-079", "generic_name": "talimogene laherparepvec", "labeler_name": "Amgen Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Imlygic", "active_ingredients": [{"name": "TALIMOGENE LAHERPAREPVEC", "strength": "100000000 [PFU]/mL"}], "application_number": "BLA125518", "marketing_category": "BLA", "marketing_start_date": "20151102", "listing_expiration_date": "20261231"}